These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 10929704)

  • 1. Medical management of obesity.
    Berke EM; Morden NE
    Am Fam Physician; 2000 Jul; 62(2):419-26. PubMed ID: 10929704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What effect does losing weight have on hypertension?].
    Engeli S
    MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
    [No Abstract]   [Full Text] [Related]  

  • 3. Combining behavioral and pharmacological treatments for obesity.
    Phelan S; Wadden TA
    Obes Res; 2002 Jun; 10(6):560-74. PubMed ID: 12055334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A practicing physician's view on obesity].
    Juhász A; Katona E; Csongrádi E; Paragh G
    Orv Hetil; 2006 Apr; 147(13):579-90. PubMed ID: 16623440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern medical management of obesity: the role of pharmaceutical intervention.
    Aronne LJ
    J Am Diet Assoc; 1998 Oct; 98(10 Suppl 2):S23-6. PubMed ID: 9787732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring synergies in the treatment of obesity.
    Wadden TA
    Postgrad Med; 2001 Jun; 109(6 Suppl):29-33. PubMed ID: 19667565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
    Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
    Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
    Richter WO
    MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of obesity.
    Hanif MW; Kumar S
    Expert Opin Pharmacother; 2002 Dec; 3(12):1711-8. PubMed ID: 12472368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging strategies for weight management. Summary.
    Hansen BC
    Postgrad Med; 2001 Jun; 109(6 Suppl):40-4. PubMed ID: 19667567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic agents for the treatment of obesity.
    Mathys M
    Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-obesity drugs: sibutramine and orlistat].
    Sempere I Verdú E; Palop Larrea V; Hidalgo Mora JJ; Martínez-Mir I
    Med Clin (Barc); 2002 Mar; 118(11):437; author reply 437-8. PubMed ID: 11943108
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.
    Sabuncu T; Nazligul Y; Karaoglanoglu M; Ucar E; Kilic FB
    Rom J Gastroenterol; 2003 Sep; 12(3):189-92. PubMed ID: 14502318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
    Wirth A
    MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
    [No Abstract]   [Full Text] [Related]  

  • 17. [Obesity in adults].
    Suter PM; Kolyvanos NU; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Oct; 96(42):1617-24; quiz 1625-6. PubMed ID: 17974121
    [No Abstract]   [Full Text] [Related]  

  • 18. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe and effective management of the obese patient.
    Collazo-Clavell ML
    Mayo Clin Proc; 1999 Dec; 74(12):1255-9; quiz 1259-60. PubMed ID: 10593355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat (Xenical) in the management of obesity.
    Cheah JS
    Ann Acad Med Singap; 2000 Jul; 29(4):419-20. PubMed ID: 11056767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.